 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Genetic Analysis, with New CEO at the Helm, Aims to Have IBS Test CE-IVD Marked This Year
February 26, 2013
Genetic Analysis, with New CEO at the Helm, Aims to Have IBS Test CE-IVD Marked This Year
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Progenika CEO Sees No 'Major Impact' After Grifols Acquires Majority Stake in Firm
March 12, 2013 / BioArray News - Luminex's 2013 Priorities Include GPP, NeoPlex Adoption, MagPix Placements, Project Aries
February 5, 2013 / BioArray News - Aiming at '$12B Opportunity,' Illumina to Expand Sales Presence, Invest in Reproductive Health
May 14, 2013 / BioArray News - Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News - GenomeWeb Feature: Will the Future of Genomics be Consumer Driven?
March 4, 2013 / GenomeWeb Daily News